Anshan Hifichem Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Anshan Hifichem's earnings have been declining at an average annual rate of -26.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 11.3% per year. Anshan Hifichem's return on equity is 7.5%, and it has net margins of 9.1%.
Wichtige Informationen
-26.7%
Wachstumsrate der Gewinne
-31.4%
EPS-Wachstumsrate
| Chemicals Wachstum der Industrie | 12.1% |
| Wachstumsrate der Einnahmen | 11.3% |
| Eigenkapitalrendite | 7.5% |
| Netto-Marge | 9.1% |
| Letzte Ertragsaktualisierung | 30 Sep 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Anshan Hifichem (SZSE:300758) Might Be Having Difficulty Using Its Capital Effectively
Oct 20
Why Investors Shouldn't Be Surprised By Anshan Hifichem Co., Ltd.'s (SZSE:300758) 27% Share Price Surge
Oct 01Anshan Hifichem (SZSE:300758) Has A Somewhat Strained Balance Sheet
Jul 26There's Reason For Concern Over Anshan Hifichem Co., Ltd.'s (SZSE:300758) Massive 30% Price Jump
May 27Anshan Hifichem (SZSE:300758) Could Be Struggling To Allocate Capital
May 06With Anshan Hifichem Co., Ltd. (SZSE:300758) It Looks Like You'll Get What You Pay For
Feb 28Aufschlüsselung der Einnahmen und Ausgaben
Wie Anshan Hifichem Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Sep 24 | 1,483 | 135 | 169 | 89 |
| 30 Jun 24 | 1,385 | 90 | 178 | 85 |
| 31 Mar 24 | 1,277 | 47 | 175 | 77 |
| 31 Dec 23 | 1,218 | 11 | 181 | 81 |
| 30 Sep 23 | 1,168 | -30 | 190 | 79 |
| 30 Jun 23 | 1,147 | -40 | 194 | 86 |
| 31 Mar 23 | 1,149 | -42 | 198 | 91 |
| 01 Jan 23 | 1,209 | -3 | 192 | 91 |
| 30 Sep 22 | 1,343 | 53 | 181 | 98 |
| 30 Jun 22 | 1,370 | 93 | 169 | 92 |
| 31 Mar 22 | 1,361 | 157 | 150 | 88 |
| 01 Jan 22 | 1,347 | 180 | 137 | 82 |
| 30 Sep 21 | 1,248 | 192 | 108 | 73 |
| 30 Jun 21 | 1,193 | 197 | 104 | 66 |
| 31 Mar 21 | 1,142 | 187 | 97 | 58 |
| 31 Dec 20 | 1,008 | 175 | 87 | 51 |
| 30 Sep 20 | 877 | 141 | 88 | 45 |
| 30 Jun 20 | 774 | 142 | 72 | 38 |
| 31 Mar 20 | 724 | 130 | 79 | 32 |
| 31 Dec 19 | 695 | 108 | 75 | 31 |
| 30 Sep 19 | 661 | 120 | 69 | 27 |
| 30 Jun 19 | 664 | 111 | 67 | 27 |
| 31 Mar 19 | 628 | 100 | 58 | 26 |
| 31 Dec 18 | 611 | 105 | 58 | 25 |
| 30 Sep 18 | 606 | 115 | 53 | 22 |
| 30 Jun 18 | 583 | 110 | 49 | 23 |
| 31 Mar 18 | 550 | 101 | 46 | 22 |
| 31 Dec 17 | 553 | 103 | 45 | 21 |
| 30 Sep 17 | 525 | 100 | 44 | 16 |
| 30 Jun 17 | 498 | 96 | 233 | 10 |
| 31 Mar 17 | 470 | 86 | 145 | 5 |
| 31 Dec 16 | 442 | 76 | 57 | 0 |
| 30 Sep 16 | 419 | 60 | -32 | 0 |
| 30 Jun 16 | 396 | 44 | -122 | 0 |
| 31 Mar 16 | 383 | 41 | -33 | 0 |
| 31 Dec 15 | 370 | 39 | 55 | 0 |
| 31 Dec 14 | 323 | 18 | 47 | 0 |
Qualität der Erträge: 300758 has high quality earnings.
Wachsende Gewinnspanne: 300758 became profitable in the past.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 300758's earnings have declined by 26.7% per year over the past 5 years.
Beschleunigtes Wachstum: 300758 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Erträge im Vergleich zur Industrie: 300758 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.8%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 300758's Return on Equity (7.5%) is considered low.